Congratulations @DrNileshPareek@m_g_mcgarvey and the team at @kingscardio to perform some first cases in the world using #Ultreon3 OCT software. Ultreon 3.0 brings AI Lipid & Calcium detection, 1-sec pullback & image based physiology insights #FFROCT
✨ Stent-Thrombosis AMI
⚠️ Early DAPT interruption = high risk
🛠 Cangrelor / GP IIb/IIIa for rapid platelet block
⏱ Tailor strategy by thrombosis timing
#StentThrombosis#PCI#AMI
🔗 Learn more:oaepublish.com/articles/2574…
Great to see @geshNHS being one the first centers globally to lead the way in full Physiology, enchanced by PPG. This utilises our one-wire full physiology solution by quantifying focal and diffuse coronary disease to help you identify patients most likely to benefit from PCI
PPG Global @TCTMD#TCT2024
💪 Patients with high PPG (focal disease) experienced less angina at 1 year
🔑 Those with low PPG had more residual angina and showed similar responses to medication, PCI, or surgery
PPG is a novel application of coronary physiology @PCRonline
This is the key advantage of MRR
🔑MMR is able to identify microvascular disease even in the presence of epicardial disease
👌🏻What is even better, it’s easy to calculate:
MRR = CFR/FFR x (Pa rest/Pa Hyper)
Amazing day in London as we hosted 100 delegates for CORE 2024.
❤️4 live cases from across Europe
❤️OCT guided bifurcation and Calcium PCI procedures
❤️Live OCT demo’ during live cases for optimised OCT learning
❤️1.5 hours hands on training for all delegates
#abbottproud
Join Optima on the 26th of March 2024, for meeting with world-renowned experts and complex PCI operators, focused on calcium modification and bifurcation strategies.
Still time to register: vascular.abbott.com/CORE-202…@AbbottCardio
#OCT Interesting cases #1
61 yo, CHILD B cirrhosis, HCC, primary sclerotic cholangitis, no known active hematologic issue
#anteriorSTEMI mid-dist LAD pPCI #Penumbra#CatRX and Heparin
Re-Look 3 days after with #OCT#Ultreon2.0
what is your diagnosis?
poll in thread
ORBITA-COSMIC is set to critically assess the Coronary Sinus Reducer's effectiveness on myocardial perfusion and angina relief through a double-blind, randomized trial, comparing it against a placebo. This study will crucially inform the clinical use of CSR for patients with advanced angina, guiding when and how this innovative approach should be integrated into treatment strategies. ow.ly/M0Im50QzbBZ
🖥️ Imaging and PCI: are we ready for a new
paradigm shift? 💡
🎯 Let's learn to use OCT before, during and after PCI; standardize the application is the goal 📈
🎯 Let's use intravascular imaging more and learn how to use it better 🥇
#GISE44#OCT#ILLUMIENIV#OCTOBER#OCTIVUS
#Abbottproud to have been a major partner and to have attended #OptimalPCI2023 event in London at the Royal College of Physicians over the last two days.
A truly fantastic educational event delivered by @OptimaCTO and expert faculty. #WHYHOWTRY
A particularly special moment to revisit @UHSFT Princess Ann Hospital Neonatal ICU to give back the equipment funded from the marathon.
💥10 height-adjustable cots
💥2 specialist oxygen saturation monitors
💥1 fridge for the family room
@IcklePickles